GelSana Therapeutics

Private

Aurora, ColoradoHealthcare & Life Scienceshttps://gelsanatherapeutics.com/

Last Round

Seed Round

Mar 6, 2026

Total Funding Raised

$2.4M

Company Overview

GelSana Therapeutics is a biomaterials company developing novel hydrogel wound dressings designed to reduce inflammation and provide sustained drug delivery for chronic wounds.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

wound carehydrogel dressingzwitterionic hydrogeladvanced wound carechronic wound managementmedical devicebiomaterialsdiabetic foot ulcerdurable medical equipmentDMEsurgical wound careburn treatmentwound healingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GelSana Therapeutics Comps

Public and private peers based on sector, stage, and business model.

GelSana Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GelSana Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed Round	Mar 6, 2026
Accelerator	Jun 5, 2025
Grant	Sep 5, 2024
Seed	Feb 19, 2024
Grant	Nov 16, 2023
Grant	Apr 1, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Melissa Krebs

CEO And Founder

Founding Team

GelSana Therapeutics Investors

Notable investors and investment history

GelSana Therapeutics investors
Investor	Rounds
MedTech Innovator	Accelerator
NIH RADx	Grant
Advanced Industries Accelerator Program	Grant
National Institute of Diabetes and Digestive and Kidney Diseases	Grant
Innosphere Ventures	Pre Seed
National Institute of Diabetes and Digestive and Kidney Diseases	Grant
Mines Venture Fund	Grant, Seed

View all Investors

GelSana Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GelSana Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GelSana Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAurora, Colorado

Employee Range8

Year Founded2020

Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.